Overview

Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether Magnetic Resonance Imaging may predict the risk of Intracerebral Hemorrhage for patients with ischemic stroke who receive indefinite oral anticoagulation
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Treatments:
Anticoagulants
Apixaban
Dabigatran
Rivaroxaban
Warfarin
Criteria
Inclusion Criteria:

1. Age > 65 y

2. TIA or ischemic stroke

3. The patient will receive indefinitely treatment with oral anticoagulants for the
secondary prevention of cardioembolic stroke

4. No previous treatment with oral anticoagulants

5. Signed consent before performing a Magnetic Resonance

6. Long-term follow-up will be possible

Exclusion Criteria:

1. The patient will receive oral anticoagulation as a primary prevention treatment

2. The etiology that motivates the onset of oral anticoagulants is not cardioembolism

3. Absolute contraindication to receive oral anticoagulants

4. Arterial hypertension that is not controlled, hypertensive crisis

5. Dementia

6. Live-expectancy less than 1 year

7. Any social or psychological reason that prevents follow-up

8. Contraindication to perform a Magnetic Resonance examination

9. Patients who received oral antiacoagulants prior to the current stroke

10. The Magnetic Resonance imaging was performed more than 1 month after the onset of
treatment with oral anticoagulants